Quick Answer
ADAPTIN BIO, INC. reported Net Income of -$161.2 thousand for fiscal year 2024.
ADAPTIN BIO, INC. — Key Financials by Year
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Income | -$161.2K -88.3% |
-$85.6K | — |
| Diluted EPS | -$0.03 -88.2% |
-$0.02 | — |
| Total Assets | $12.6K +3220.8% |
$380.00 -24.0% |
$500.00 |
| Cash and Equivalents | — | $380.00 -24.0% |
$500.00 |
| Stockholders Equity | -$274.1K -142.7% |
-$112.9K -313.5% |
-$27.3K |
| Operating Income | -$155.4K -81.5% |
-$85.6K | — |
| Shares Outstanding | 5.00M +0.0% |
5.00M +0.0% |
5.00M |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | -$1.68M | -51.3% | -10.2% |
| Diluted EPS | September 30, 2025 | -$0.20 | +41.2% | -11.1% |
| Total Assets | September 30, 2025 | $979.5K | +304084.5% | -41.1% |
| Cash and Equivalents | September 30, 2025 | $579.1K | — | +1599.0% |
| Stockholders Equity | September 30, 2025 | -$881.1K | +72.8% | -285.7% |
| R&D Expense | September 30, 2025 | $778.7K | +14.1% | +128.8% |
| Operating Income | September 30, 2025 | -$1.68M | -68.4% | -10.2% |
| Shares Outstanding | September 30, 2025 | 8.46M | +69.1% | +0.0% |
- ADAPTIN BIO, INC. reported Net Income of -$161.2 thousand for fiscal year 2024.
- ADAPTIN BIO, INC. showed a decrease of -88.3% in Net Income compared to the prior fiscal year.
- ADAPTIN BIO, INC. reported Diluted EPS of $0.03 per share (loss) for fiscal year 2024.
- ADAPTIN BIO, INC. showed a decrease of -88.2% in Diluted EPS compared to the prior fiscal year.
- ADAPTIN BIO, INC. reported Total Assets of $12.6 thousand for fiscal year 2024.
- ADAPTIN BIO, INC. showed an increase of +3220.8% in Total Assets compared to the prior fiscal year.
- ADAPTIN BIO, INC. reported Cash and Equivalents of $380.00 for fiscal year 2023.
- ADAPTIN BIO, INC. showed a decrease of -24.0% in Cash and Equivalents compared to the prior fiscal year.
- ADAPTIN BIO, INC. reported Stockholders Equity of -$274.1 thousand for fiscal year 2024.
- ADAPTIN BIO, INC. showed a decrease of -142.7% in Stockholders Equity compared to the prior fiscal year.
- ADAPTIN BIO, INC. reported Operating Income of -$155.4 thousand for fiscal year 2024.
- ADAPTIN BIO, INC. showed a decrease of -81.5% in Operating Income compared to the prior fiscal year.
- ADAPTIN BIO, INC. reported Shares Outstanding of 5.00 million shares for fiscal year 2024.
- ADAPTIN BIO, INC. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: